Get the Stockscreener App
21.12
3.07%
-0.67
Pre-market:
21.13
0.010
+0.05%
Medifast Inc stock is traded at $21.12, with a volume of 2.33M.
It is down -3.07% in the last 24 hours and up +3.28% over the past month.
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.
See More
Previous Close:
$21.79
Open:
$22.14
24h Volume:
2.33M
Relative Volume:
2.43
Market Cap:
$5.94B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-3.87%
1M Performance:
+3.28%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$21.09
$22.30
1-Week Range:
$21.09
$23.36
52-Week Range:
$15.40
$24.43
Medifast Inc Stock (MMED) Company Profile
Name
Medifast Inc
Sector
Industry
Phone
763-222-9423
Address
18000 DEVONSHIRE ST., NORTHRIDGE
Compare MMED vs ROL, SCI, ANDG, FTDR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MMED
Medifast Inc
|
21.12 | 6.33B | 0 | 0 | 0 | 0.00 |
ROL
Rollins Inc
|
32.35 | 16.71B | 3.84B | 529.30M | 621.14M | 1.0945 |
SCI
Service Corp International
|
77.56 | 11.20B | 4.33B | 535.79M | 486.05M | 3.79 |
ANDG
Andersen Group Inc
|
54.65 | 6.06B | 871.37M | -163.01M | 0 | 1.0456 |
FTDR
Frontdoor Inc
|
79.73 | 5.58B | 2.12B | 260.00M | 385.00M | 3.5067 |
Medifast Inc Stock (MMED) Latest News
BlackRock Inc. Makes New Investment in Medifast Inc $MED - MarketBeat
Medifast (MED) Reports Q2 Loss, Beats Revenue Estimates - Eastern Progress
Medifast (NYSE:MED) Stock Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
Medifast's 3.0 Strategy Takes Shape: Can It Restore Profitable Growth? - Eastern Progress
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound? - Eastern Progress
Why Is Medifast (MED) Down 7.6% Since Last Earnings Report? - Yahoo Finance
MEDIFAST INC (MED) Peer Comparison – Compare with Others - valueresearchonline.com
Medifast Launches the Medifast Metabolic Health Institute - Direct Selling News
MEDIFAST INC (MED) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Medifast director Kiai Parsa buys $529k in MED stock By Investing.com - Investing.com Nigeria
Medifast (NYSE: MED) director adds 43K shares in open-market buy - Stock Titan
MEDIFAST INC (MED) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Medifast (NYSE:MED) Director Purchases 43,150 Shares - MarketBeat
Medifast® Announces the Launch of the Medifast Metabolic Health Institute™ - Yahoo Finance
Medifast director Kiai Parsa buys $51,973 of common stock - Bitget
All You Need to Know About Medifast (MED) Rating Upgrade to Buy - Eastern Progress
Steamboat Capital Partners, LLC Adds to Medifast Inc (MED) Stake -- Shares Trade 46% Above GF Value - GuruFocus
MEDIFAST (MED) Financial Update: EPS Exceeds Its Estimate for the Current Session; Closing Reaction: Shares Move 0.42% Up on the DayRevenue Report - vinanet.vn
MED | Medifast, Inc. FinancialsRevenue Breakdown - Quiver Quantitative
Medifast (NYSE: MED) sees Steamboat Capital build 790,693-share stake - Stock Titan
Medifast (NYSE:MED) Director Purchases 43,150 Shares of Stock - MarketBeat
Insider Buying: Medifast (NYSE:MED) Director Acquires 29,337 Shares of Stock - MarketBeat
Medifast director Parsa Kiai acquires $842,698 in company shares By Investing.com - Investing.com Nigeria
Medifast director Parsa Kiai acquires $842,698 in company shares - Investing.com
Medifast (NYSE: MED) director buying near $11 — see how many shares he added - Stock Titan
Can Medifast's New Compensation Plan Accelerate Coach Growth? - TradingView
MEDIFAST (MED) Results Versus Estimates: EPS Beats Its Estimate; After Results: The Stock Records a 0.35% Increase - vinanet.vn
MEDIFAST (MED) Earnings Update: EPS Prints Above Forecast in the Latest Session; Closing Move - vinanet.vn
How the Needle is Moving on This Health and Wellness Stock: Medifast, Inc. - Kalkine
MEDIFAST (MED) Holds Key Support at $10.87 as Stock Edges LowerTriple EMA - vinanet.vn
Medifast (MED): Citadel entities and Kenneth Griffin disclose sub‑5% ownership stake - Stock Titan
Susquehanna group reports 5.3% Medifast (MED) ownership in Schedule 13G - Stock Titan
Medifast (NYSE:MED) Cut to Hold at Zacks Research - MarketBeat
Medifast (MED): Charles Schwab Investment Management reports 3.6% ownership stake - Stock Titan
Can Medifast's Coach Productivity Gains Help Revive Revenue Growth? - Yahoo Finance
Medifast’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Medifast (MED) Q2 2026 Earnings Call Transcript - AOL.com
MEDIFAST (MED) Declines 2.85% to $11.74 as Support at $11.15 Comes Under ScrutinyETF NAV Deviation - vinanet.vn
Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround? - TradingView
MED Rallies 13.6% in the Past Month: Can the Momentum Keep Building? - TradingView
Is MED Worth Buying as Low Valuation Meets a High-Risk Turnaround? - TradingView
Why Medifast (MED) Stock Is Trading Up Today - Yahoo Finance
Medifast: Worth A Speculative Entry As Sales Stabilize (Rating Upgrade) - Seeking Alpha
Medifast rebrands flagship diet product amid pressure from GLP-1s - The Business Journals
Medifast Q2 Loss Narrower Than Expected, Coach Productivity Improves - finance.yahoo.com
Medifast, Inc. Q2 2026 Earnings Call Summary - finance.yahoo.com
Medifast Inc (MED) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Trilivy and ... By GuruFocus - Investing.com Canada
Medifast Inc (MED) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Trilivy and ... - Yahoo Finance
Medifast Q2 loss widens as coach base shrinks by 48.7% - scanx.trade
Medifast Q2 Earnings Call Highlights - MarketBeat
Medifast, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:MED) 2026-08-03 - Seeking Alpha
Medifast Inc Stock (MMED) Financials Data
There is no financial data for Medifast Inc (MMED). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.62%
1.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):